1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2022 - Northern Europe

Chronic Disease Analysis & Statistics 2022 - Northern Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Euromonitor International

All regions

  • All
    • Europe
      • Northern Europe

data types

1-9 of 9 reports

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania

  • $ 990
  • November 2021
  • 24 pages

Cough, cold and allergy (hay fever) remedies continues to see a sharp deceleration in retail value sales growth during 2021 due to the impact of COVID-19. Indeed, cough, cold and allergy (hay fever) remedies ...

  • Lithuania
  • OTC
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Latvia

  • $ 990
  • October 2021
  • 23 pages

Cough, cold and allergy (hay fever) remedies will see even stronger current value declines in 2021 as COVID-19 measures reduce the potential of catching common colds. Such measures include lockdown restrictions ...

  • Latvia
  • OTC
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Online Expenditure

Cough, Cold and Allergy (Hay Fever) Remedies in Ireland

  • $ 990
  • October 2021
  • 25 pages

Having plunged by almost a quarter during 2020, retail current value sales of cough, cold and allergy (hay fever) remedies will continue to fall in 2021 – albeit at a more modest pace. Measures intended ...

  • Ireland
  • Hay
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Vitamin Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Estonia

  • $ 990
  • October 2021
  • 23 pages

Sales of cough, cold and allergy (hay fever) remedies continue to be impacted by COVID-19 in 2021, registering further double-digit current value decline. Consumers continue to take precautions due to ...

  • Estonia
  • OTC
  • Hay
  • Industry analysis
  • Life Expectancy
  • Online Retail Sales

Cough, Cold and Allergy (Hay Fever) Remedies in the United Kingdom

  • $ 990
  • October 2021
  • 27 pages

Following government measures to stop the spread of COVID-19, the lockdown was extended until mid-Q2 2021. This meant that with fewer opportunities to go out, the general public mostly stayed indoors with ...

  • United Kingdom
  • Hay
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Greenhouse Gas Emissions

Cough, Cold and Allergy (Hay Fever) Remedies in Norway

  • $ 990
  • September 2021
  • 27 pages

Following strong growth in 2020 due to COVID-19 and purchases of cough remedies and nasal sprays for use during self-quarantine, cough, cold and allergy (hay fever) remedies is projected to see a small ...

  • Norway
  • Allergy
  • Hay
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Sweden

  • $ 990
  • September 2021
  • 24 pages

After seeing a notable decline in current value terms in 2020, cough, cold and allergy (hay fever) remedies is set to continue this negative trend in 2021. Cough, Cold and Allergy (Hay Fever) Remedies ...

  • Sweden
  • Allergy
  • Hay
  • Industry analysis
  • Life Expectancy
  • Store Closures

Cough, Cold and Allergy (Hay Fever) Remedies in Denmark

  • $ 990
  • September 2021
  • 24 pages

Cough, cold and allergy remedies is expected to register a small increase in current value sales in 2021 as the segment corrects itself after the decline in 2020, which was caused by a smaller prevalence ...

  • Denmark
  • OTC
  • Allergy
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Finland

  • $ 990
  • September 2021
  • 23 pages

Cough, cold and allergy (hay fever) remedies is expected to register negative current value growth for the second year running, though the decline will not be as significant as in 2020, when it was in ...

  • Finland
  • OTC
  • Allergy
  • Industry analysis
  • Over The Counter Drug Sales
  • Prescription Drug Sales


About 600 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Global Stroke and Dementia Social Impact

  • January 2022
  • 16 pages
  • East Asia
  • China
  • Dementia
  • Stroke
  • Industry analysis
  • Dementia Prevalence
  • Life Expectancy

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on